LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 4 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,039 | -16.3% | 83,931 | 0.0% | 0.02% | -18.5% |
| Q2 2023 | $118,343 | +6.7% | 83,931 | +13.5% | 0.03% | -3.6% |
| Q1 2023 | $110,897 | +12.9% | 73,931 | -11.9% | 0.03% | -12.5% |
| Q4 2022 | $98,199 | +3.4% | 83,931 | 0.0% | 0.03% | 0.0% |
| Q3 2022 | $95,000 | -24.0% | 83,931 | +6.3% | 0.03% | -22.0% |
| Q2 2022 | $125,000 | +6.8% | 78,931 | +4.0% | 0.04% | +20.6% |
| Q1 2022 | $117,000 | -10.0% | 75,931 | +43.5% | 0.03% | -10.5% |
| Q4 2021 | $130,000 | +7.4% | 52,931 | +10.4% | 0.04% | -5.0% |
| Q3 2021 | $121,000 | -11.7% | 47,931 | 0.0% | 0.04% | -13.0% |
| Q2 2021 | $137,000 | +29.2% | 47,931 | +6.7% | 0.05% | +9.5% |
| Q1 2021 | $106,000 | – | 44,931 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $39,477,000 | 3.01% |
| Raffles Associates | 2,080,536 | $2,351,000 | 2.51% |
| Defender Capital, LLC. | 5,184,035 | $5,862,000 | 2.30% |
| Prescott General Partners LLC | 1,851,851 | $2,093,000 | 0.16% |
| DAFNA Capital Management LLC | 140,000 | $158,000 | 0.04% |
| Fort Sheridan Advisors LLC | 83,931 | $95,000 | 0.03% |
| Long Focus Capital Management, LLC | 215,000 | $243,000 | 0.02% |
| XTX Topco Ltd | 72,807 | $82,000 | 0.02% |
| Ergoteles LLC | 490,895 | $555,000 | 0.02% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $51,000 | 0.02% |